Harrow has finalized a 5-year strategic supply and development (SSD) agreement to ensure the continu...

Kodiak Sciences has successfully completed patient enrollment for its Phase 3 GLOW2 trial, evaluatin...

Physicians’ Education Resource® (PER) has introduced Retina Resource, a specialized educational plat...

4D Molecular Therapeutics (4DMT) has officially commenced its Phase 3 clinical program for 4D-150, e...

OKYO Pharma has officially filed an application with the U.S. Food and Drug Administration (FDA) see...

Luxa Biotechnology has presented clinical data from its Phase 1/2a trial evaluating RPESC-RPE-4W at ...

Lumata Health has raised $23 million in Series B funding, bringing its total funding to $36 million ...

Optos has announced the launch of MonacoPro, the next-generation ultra-widefield (UWF) SLO and spect...

Avirmax Biopharma has announced the initiation of Investigational New Drug (IND)-enabling studies fo...

Haag-Streit has officially launched the METIS 900, a cutting-edge ophthalmic surgical microscope des...